相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Protein Arginine Methyltransferases in Neuromuscular Function and Diseases
Jinwoo Lee et al.
CELLS (2022)
PRMT1 enhances oncogenic arginine methylation of NONO in colorectal cancer
Xin-Ke Yin et al.
ONCOGENE (2021)
Synergistic effects of type I PRMT and PARP inhibitors against non-small cell lung cancer cells
Claudia Dominici et al.
CLINICAL EPIGENETICS (2021)
PRMT1 promotes the tumor suppressor function of p14ARF and is indicative for pancreatic cancer prognosis
Antje Repenning et al.
EMBO JOURNAL (2021)
PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling
Bing Yao et al.
GENOME MEDICINE (2021)
The methyltransferase PRMT1 regulates γ-globin translation
Ying Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Global analysis of protein arginine methylation
Fangrong Zhang et al.
CELL REPORTS METHODS (2021)
PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma
Jianfeng Wang et al.
THERANOSTICS (2021)
Pharmacophore-based screening of diamidine small molecule inhibitors for protein arginine methyltransferases
Kun Qian et al.
RSC MEDICINAL CHEMISTRY (2021)
The development of a novel transforming growth factor-β (TGF-β) inhibitor that disrupts ligand-receptor interactions
Han Wu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Development of small molecule inhibitors targeting TGF-β ligand and receptor: Structures, mechanism, preclinical studies and clinical usage
Hao Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
PRMT1 promotes neuroblastoma cell survival through ATF5
Zhong-Yan Hua et al.
ONCOGENESIS (2020)
Epithelial-Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis
Francesco Salton et al.
MEDICINA-LITHUANIA (2019)
Downregulation of PRMT1 promotes the senescence and migration of a non-MYCN amplified neuroblastoma SK-N-SH cells
Yu-Jen Lee et al.
SCIENTIFIC REPORTS (2019)
Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss
Andrew Fedoriw et al.
CANCER CELL (2019)
The Development of Tetrazole Derivatives as Protein Arginine Methyltransferase I (PRMT I) Inhibitors
Yutong Sun et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Protein arginine methyltransferase 1 promotes epithelial-mesenchymal transition via TGF-β1/Smad pathway in hepatic carcinoma cells
H. Wei et al.
NEOPLASMA (2019)
Arginine methylation of SMAD7 by PRMT1 in TGF-β-induced epithelial-mesenchymal transition and epithelial stem-cell generation
Yoko Katsuno et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Epithelial Mesenchymal Transition in Tumor Metastasis
Vivek Mittal
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 13 (2018)
Mechanisms and Inhibitors of Histone Arginine Methylation
Melody D. Fulton et al.
CHEMICAL RECORD (2018)
Arginine Methylation: The Coming of Age
Romeo S. Blanc et al.
MOLECULAR CELL (2017)
Design and synthesis of novel PRMT1 inhibitors and investigation of their binding preferences using molecular modelling
Hao Yang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Discovery and structure-activity analysis of 4-((5-nitropyrimidin-4-yl)amino)benzimidamide derivatives as novel protein arginine methyltransferase 1 (PRMT1) inhibitors
Xu-Ri Yu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Diamidine Compounds for Selective Inhibition of Protein Arginine Methyltransferase 1
Leilei Yan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Histone arginine methylation
Alessandra Di Lorenzo et al.
FEBS LETTERS (2011)
PRMT-1 and DDAHs-induced ADMA upregulation is involved in ROS- and RAS-mediated diabetic retinopathy
Yihui Chen et al.
EXPERIMENTAL EYE RESEARCH (2009)
Target-based approach to inhibitors of histone arginine methyltransferases
Astrid Spannhoff et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Small molecule regulators of protein arginine methyltransferases
DH Cheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
分享论文
